| |
| |
|
| Insider
Information: |
Capello Jeffrey D |
| Relationship: |
EVP & Chief Financial ... |
| City: |
Wellesley |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
106,104 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$10,317,008 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
106,104 |
|
|
| Total
Value |
$10,317,008 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Perkinelmer Inc |
PKI |
SVP & CFO |
2008-01-29 |
91,428 |
2004-01-27 |
0 |
Premium* |
|
|
Boston Scientific Corp |
BSX |
EVP & Chief Financial ... |
2013-11-27 |
447 |
2009-06-16 |
0 |
Premium* |
|
|
Tempest Therapeutics, Inc |
TPST |
Director |
2013-03-18 |
11,111 |
2013-03-18 |
0 |
Premium* |
|
|
Biogen Idec Inc |
BIIB |
EVP & Chief Financial ... |
2020-02-12 |
3,118 |
2019-01-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
68 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PKI |
Perkinelmer Inc |
Chief Accounting Officer |
• – – |
2004-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
20,000 |
|
- |
|
| PKI |
Perkinelmer Inc |
officerTitle |
• – – |
2006-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
20,226 |
0 |
|
- |
|
| PKI |
Perkinelmer Inc |
SVP & CFO |
• – – |
2007-01-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,334) |
54,246 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
SVP & CFO |
• – – |
2007-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
18,893 |
73,139 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
SVP & CFO |
• – – |
2008-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
17,699 |
91,428 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP, Chief Accounting Officer |
• – – |
2009-06-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,325 |
29,325 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP, Chief Accounting Officer |
• – – |
2010-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,012 |
23,026 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
• – – |
2010-06-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
73,314 |
95,196 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
• – – |
2011-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,244 |
89,541 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
• – – |
2011-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,065 |
91,065 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
• – – |
2011-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,012 |
91,516 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
• – – |
2011-06-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,662 |
105,221 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
• – – |
2012-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,242 |
120,807 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
• – – |
2012-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,064 |
122,151 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
• – – |
2012-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,012 |
122,606 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
• – – |
2012-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,475 |
132,126 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
• – – |
2012-05-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,236 |
136,041 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
• • – |
2013-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,244 |
164,005 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
• • – |
2013-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,065 |
165,412 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
• • – |
2013-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,012 |
165,794 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
• • – |
2013-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,312 |
183,124 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
• • – |
2013-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,474 |
187,628 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
• • – |
2013-05-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,235 |
191,448 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
• • – |
2013-06-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,665 |
203,754 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP & Chief Financial Officer |
• • – |
2019-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,331 |
1,331 |
0 |
- |
|
68 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
